Determination of Pinaverium Bromide in pharmaceutical dosage forms by a validated Stability-Indicating LC Method
DOI:
https://doi.org/10.22456/2527-2616.73964Keywords:
pinaverium bromide, experimental design, liquid chromatography, stability-indicating method, validationAbstract
A reversed-phase liquid chromatography (LC) method is validated for the determination of pinaverium bromide (PB) in pharmaceutical dosage forms. The LC method is carried out on a reversed-phase monolithic C18 column (100 x 4.6 mm i.d.), maintained at 45 ºC. The mobile phase consisted of acetonitrile and a solution of triethylamine 0.3% pH 5.0 (50:50; v/v), run at a flow rate of 2.0 mL/min, with photodiode array detector set at 213 nm. The chromatographic separation is obtained with PB retention time of 3.4 min, and it is linear in the range of 5-100 μg/mL (r2 = 0.9991). The limits of detection and quantitation are 1.41 and 4.70 μg/mL, respectively. The specificity and stability-indicating capability of the method are proven through degradation studies, which also showed that there is no interference of the formulation excipients, showing that peak is free from any coeluting peak. The method showed adequate precision, with a relative standard deviation values lower than 1.38%. Excellent values of accuracy were also obtained, with a mean value of 100.68%. Experimental design is used during validation to calculate and prove method robustness. The proposed LC method is applied for the analysis of the PB pharmaceutical dosage forms, contributing to improve the quality control and to assure the therapeutic efficacy.Downloads
References
Ikechi, R., Fischer, B.D., DeSipio, J., Phadtare, S. Irritable bowel syndrome: clinical manifestations, dietary influences, and management. Healthcare. 2017; 5(21): 1-14.
World Gastroenterology Organisation (WGO). Global Guidelines Irritable Bowel Syndrome: a Global Perspective. Milwaukee, USA, 2015. 28p.
Weaver, K.R., Melkus, G.D., Henderson, W.A. Irritable bowel syndrome. Am J Nurs. 2017; 117(6): 48-55.
Annaházi, A., Róka, R., Rosztóczy, A., Wittmann, T. Role of antispasmodics in the treatment of irritable bowel syndrome. World J Gastroenterol. 2014; 20(20): 6031-6043.
Zheng, L., Lai, Y., Lu, W., Li, B., Fan, H., Yan, Z., et al. Pinaverium reduces symptoms of irritable bowel syndrome in a multicenter, randomized, controlled trial. Clin Gastroenterol H. 2015; 13: 1285-1292.
Ramachandra, B. Development of impurity profiling methods using modern analytical techniques. Crit Rev Anal Chem. 2017; 47(1): 24-36.
Kątny, M., Frankowski, M.. Impurities in drug products and active pharmaceutical ingredients. Crit Rev Anal Chem. 2017; 47(3): 187-193.
Sahu, P.K., Ramisetti, N.R., Cecchi, T., Swain, S., Patro, C.S., Panda, J. An overview of experimental designs in HPLC method development and validation. J Pharm Biomed Anal. 2017; in press.
Skibinski, R., Trawinski, J. Application of an untargeted chemometric strategy in the impurity profiling of pharmaceuticals: an example of amisulpride. J Chromatogr Sci. 2017; 55(3): 309-315.
Holm, R., Elder, D.P. Analytical advances in pharmaceutical impurity profiling. Eur J Pharm Sci. 2016; 87: 118-135.
Jandera, P., Hájek, T., Sandra, P. Monolithic and core-shell columns in comprehensive twodimensional HPLC: a review. Anal Bioanal Chem. 2015; 407: 139-151.
Sangoi, M.S., Todeschini, V., Steppe, M.. Monolithic LC method applied to fesoterodine fumarate low dose extended-release tablets: dissolution and release kinetics. J Pharm Anal. 2015; 5(2): 137-141.
Ibrahim, F., Wahba, M.E.K. Simultaneous liquid chromatographic determination of ebastine with two sympathomimetic drugs using a monolithic column. J Chromatogr Sci. 2017; 55(3): 258-266.
Martins, D.F.C., Florindo, L.C., Machado, A.K.M.S., Todeschini, V., Sangoi, M.S. Bromide pinaverium: development and validation of spectrophotometric methods for assay and dissolution studies. J AOAC Int. 2017; in press.
International Conference on Harmonization (ICH) of Technical Requirements for the Registration of Pharmaceutical for Human Use. Validation of Analytical Procedures: Text and Methodology Q2(R1). Geneva, Switzerland, 2005. 17p.
Food and Drug Administration (FDA), Center for Drug Evaluation and Research. Guidance for Industry: Analytical Procedures and Methods Validation for Drugs and Biologics. Silver Spring, USA, 2015. 18p.
Singh, S., Junwal, M., Modhe, G., Tiwari, H., Kurmi, M., Parashar, N., et al. Forced degradation studies to assess the stability of drugs and products. Trac-Trend Anal Chem. 2013; 49: 71-88.
Blessy, M., Patel, R.D., Prajapati, P.N., Agrawal, Y.K. Development of forced degradation and stability indicating studies of drugs - a review. J Pharm Analysis. 2014; 4(3): 159-165.
Lenth, R.V. Quick and easy analysis of unreplicated factorials. Technometrics. 1989; 31: 469-473.
Downloads
Published
Versions
- 10-03-2026 (4)
- 08-03-2026 (3)
- 06-03-2026 (2)
- 28-08-2017 (1)
How to Cite
Issue
Section
License
Copyright (c) 2017 Drug Analytical Research
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The Copyright holder of manuscripts published is Drug Analytical Research. Authors who publish with this journal are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Licensing:
Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License
Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author.
